Dong-a St Co., Ltd.

This study tests whether adding a third drug (DA5221-T) to an existing two-drug combination can improve blood sugar control in adults with type 2 diabetes. About 174 participants who are not meeting their blood sugar goals will receive either the extra drug or a placebo for 24 we…

This study looks at how taking DA-5223 with or without food changes the way the body absorbs the drug. Healthy adults aged 19 to 55 will receive a single dose under different meal conditions. The goal is to understand food effects, not to treat any disease.